Bitterroot Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $145M

  • Investors
  • 5

Bitterroot Bio General Information

Description

Operator of a biotechnology company intended to develop and deliver therapies for patients with cardiovascular disease. The company harnesses the immune system's natural ability to fight disease and through its research discovers the critical roles that immune cells and immune modulators play in the development and progression of cardiovascular disease, enabling medical professionals to access suitable medicines to transform the way cardiovascular diseases are treated.

Contact Information

Website
www.brbio.com
Formerly Known As
48
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3160 Porter Drive
  • Suite 220
  • Palo Alto, CA 94304
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3160 Porter Drive
  • Suite 220
  • Palo Alto, CA 94304
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bitterroot Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 07-Jun-2023 $145M Completed Pre-Clinical Trials
To view Bitterroot Bio’s complete valuation and funding history, request access »

Bitterroot Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
To view Bitterroot Bio’s complete cap table history, request access »

Bitterroot Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to develop and deliver therapies for patients with cardiovascular disease.
Drug Discovery
Palo Alto, CA
25 As of 2026

Boston, MA
 

Burlington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bitterroot Bio Competitors (4)

One of Bitterroot Bio’s 4 competitors is Verve Therapeutics, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verve Therapeutics Formerly VC-backed Boston, MA
Cardurion Venture Capital-Backed Burlington, MA
Tenaya Therapeutics Formerly VC-backed South San Francisco, CA
Tourmaline Bio Formerly VC-backed New York, NY
To view Bitterroot Bio’s complete competitors history, request access »

Bitterroot Bio Patents

Bitterroot Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026148294-A1 Treatment methods using sirp-alpha fc fusion polypeptides Pending 06-Jan-2025
WO-2023183890-A1 Multivalent sirp-alpha fusion polypeptides Inactive 24-Mar-2022
JP-2025510774-A Sirp-alpha fusion polypeptides having modified fc domains Pending 24-Mar-2022
AU-2023240361-A1 Sirp-alpha fusion polypeptides with modified fc domains Pending 24-Mar-2022
EP-4499837-A1 Sirp-alpha fusion polypeptides with modified fc domains Pending 24-Mar-2022 C07K14/70503
To view Bitterroot Bio’s complete patent history, request access »

Bitterroot Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bitterroot Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
ARCH Venture Partners Venture Capital Minority
Deerfield Management Venture Capital Minority
GV Corporate Venture Capital Minority
Koch Disruptive Technologies Venture Capital Minority
To view Bitterroot Bio’s complete investors history, request access »

Bitterroot Bio Acquisitions (1)

Bitterroot Bio’s most recent deal was a Merger/Acquisition with Miga. The deal was made on 25-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Miga 25-Apr-2025 Merger/Acquisition Diagnostic Equipment
To view Bitterroot Bio’s complete acquisitions history, request access »

Bitterroot Bio Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Miga San Francisco, CA 2021

Bitterroot Bio FAQs

  • When was Bitterroot Bio founded?

    Bitterroot Bio was founded in 2021.

  • Where is Bitterroot Bio headquartered?

    Bitterroot Bio is headquartered in Palo Alto, CA.

  • What is the size of Bitterroot Bio?

    Bitterroot Bio has 25 total employees.

  • What industry is Bitterroot Bio in?

    Bitterroot Bio’s primary industry is Drug Discovery.

  • Is Bitterroot Bio a private or public company?

    Bitterroot Bio is a Private company.

  • What is the current valuation of Bitterroot Bio?

    The current valuation of Bitterroot Bio is .

  • What is Bitterroot Bio’s current revenue?

    The current revenue for Bitterroot Bio is .

  • How much funding has Bitterroot Bio raised over time?

    Bitterroot Bio has raised $145M.

  • Who are Bitterroot Bio’s investors?

    Alexandria Venture Investments, ARCH Venture Partners, Deerfield Management, GV, and Koch Disruptive Technologies have invested in Bitterroot Bio.

  • Who are Bitterroot Bio’s competitors?

    Verve Therapeutics, Cardurion, Tenaya Therapeutics, and Tourmaline Bio are competitors of Bitterroot Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process